Viewing Study NCT06047652



Ignite Creation Date: 2024-05-06 @ 7:31 PM
Last Modification Date: 2024-10-26 @ 3:08 PM
Study NCT ID: NCT06047652
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-09-21
First Post: 2023-08-25

Brief Title: Development of Electronic Continuing Professional Development for Indonesian Clinical Nurses
Sponsor: Universitas Muhammadiyah Yogyakarta
Organization: Universitas Muhammadiyah Yogyakarta

Study Overview

Official Title: Electronic Continuing Professional Development e-CPD Implementation Process and Outcomes for Indonesian Clinical Nurses An Exploratory Action Research Study Protocol
Status: NOT_YET_RECRUITING
Status Verified Date: 2023-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: e-CPD
Brief Summary: The goal of this clinical trial is to test a e-CPD prototype device for feasibility as it is applied within the clinical nursing setting in Level II clinical nurses in Indonesia The main questions it aims to answer are

What are the user needs for clinical nurse e-CDP development
How is an instructional design developed for the development of e-CPD for clinical nurses
What is the most suitable e-CPD format for clinical nurses
How is the feasibility of e-CPD prototype
Detailed Description: This research is an exploratory action research This design is principally exploratory research plan to explore - explore - analyse and reflect followed by action research plan to change - act - observe - reflect

1 Exploration

This stage includes the plan to explore stage or stage 1 of 7 research stages This stage prepares before collecting data Researchers will start by building good interpersonal relationships with participants and the research environment A good relationship can also create trust to improve the quality of the data collected At this stage researchers also compiled interview guidelines for 3 groups of participants

The next stage is exploring which is stage 2 of the 7 stages of existing research This stage conducts data collection through FGD to 3 groups of participants The explanation of the implementation of the FGD is as follows

FGD on nurses will be conducted on 8-10 nurses who have performed CPD and have followed the credentials carried out by the hospital The purpose of this FGD with nurses is to explore understanding experience obstacles efforts made to overcome obstacles and expectations on the implementation of CPD

FGD on hospital management will be conducted on 8-10 hospital managers who had a role in the implementation of nurse CPD The interview explores hospitals management policies barriers and efforts in implementing nurse CPD Interviews with hospital management were conducted simultaneously at almost the same time as the nurses FGD

FGD on the Indonesian Nurses Association committee will be conducted on 8-10 committee members who have direct authority in the implementation of CPD The FGD focuses on the policies barriers and efforts that professional organizations make on nurse CPD

The analysis and reflect stage or stage 3 of the 7 stages of this research will be carried out by analysing the results of the FGD These results will used as a basis for determining strategic issues and potential solutions to the problems in this study

The interview will be conducted by 2 people namely researchers and research assistants Verbatim transcripts will be performed immediately after the interview is conducted by research assistants who follow the course of the interview
2 Action

This stage will begin with the plan to change the 4th stage of 7 stages of research This stage aims to draw up an instructional design that will form the basis for the development of the e-CPD system Activities will be carried out with a series of workshops 2 times to get mutual agreement The workshop will be attended by nurse managers The Indonesian Nurses Association representatives clinical nurse assessors and nurses in charge of care The results of stage 4 will produce the Clinical Nurse II Competency Training Curriculum At this stage an expert review is also carried out to assess the suitability of the module preparation with existing provisions Expert reviews will also be conducted to ensure that the curriculum has met the established rules At this stage researchers identify the ability of clinical nurses as the primary users required features learning media assignments and assessments set

The next stage is act which is stage 5 of the 7 stages of research This stage will carried out through the development of the e-CPD system Researchers in collaboration with IT professionals will develop an e-CPD system designed to be able to facilitate the learning process as well as evaluation according to the curriculum that has been compiled At this stage the e-CPD system is also reviewed by the same experts who provide curriculum reviews This is done so that the e-CPD system is built in accordance with the curriculum that has been prepared

The observation stage stage 6 of the 7 existing research stages will carry out user testing User testing aims to test the functionality of the e-CPD design that has been developed User testing was carried out on 10 nurses who will become users of this system with the criteria level I clinical nurses who work in hospitals have gadgets and are willing to participate in the e-CPD system trial The instruments used use the System Usability Scale SUS Participants will be asked to access and try all the features of the e-CPD application Then participants will be asked to complete an SUS questionnaire containing 10 questions through Google Forms This questionnaire contains ease of access and possible use for these participants

Reflect stage is the last stage stage 7 of the 7 At this stage analysis and evaluation of the entire study that has been carried out and determine follow-up

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None